Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

eSense-Lab Ltd

INVESTOR PRESENTATION - eSense-Lab Ltd

ASX:ESE

eSense-Lab Ltd

Health

eSense-Lab Ltd (ESE) is a unique pharmatech company with multi- disciplinary R&D expertise, unique reverse engineering capabilities, and game-changing techniques that enable us to re- engineer the chemical composition found in plants, and re- formulate them for numerous commercial applications. The Company is a technology and research and development company specializing in the commercialization of the phytochemical profiling of plants. The Company combines genetics, mRNA, protein expression and phytochemical profiles to generate a comprehensive model of targeted plants.

Read more

Market Cap

$9.18m

Price at Close

$0.018

4w avg. Volume

0.00

4w avg. Turnover

$0.00

Announcements
announcementt+2 movementdate
  • eSense Secures Working Capital Funding

    Periodic Reports

  • 0.00%

    29 Dec 2020

0.00%

29 Dec 2020
  • Investor Presentation

    Periodic Reports

  • 0.00%

    09 Dec 2020

0.00%

09 Dec 2020
  • Board and Management Changes

    Company Administration · Market sensitive

  • 0.00%

    04 Dec 2020

0.00%

04 Dec 2020
  • Update on Research Agreement with Israeli MOH

    Progress Report · Market sensitive

  • 0.00%

    26 Nov 2020

0.00%

26 Nov 2020
  • Final Director's Interest Notice

    Shareholder Details

  • 0.00%

    03 Nov 2020

0.00%

03 Nov 2020
  • Quarterly Activities Report and Appendix 4C

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    03 Nov 2020

0.00%

03 Nov 2020
  • Appendix 4D and Half Year Accounts

    Periodic Reports · Market sensitive

  • 0.00%

    31 Aug 2020

0.00%

31 Aug 2020
  • Israel Ministry of Health Research Agreement to Test TRP-ENV

    Progress Report · Market sensitive

  • 0.00%

    31 Aug 2020

0.00%

31 Aug 2020
  • Initial Director's Interest Notice

    Shareholder Details

  • 0.00%

    31 Jul 2020

0.00%

31 Jul 2020
  • Voluntary Suspension Update

    Company Administration · Market sensitive

  • 0.00%

    31 Jul 2020

0.00%

31 Jul 2020
Market Data

Current Price

$0.018

52WK HIGH

$0.052

52WK LOW

$0.004

1YR RETURN

+28.57%

1YR RETURN VS. SECTOR

-8.94%

90 DAY RETURN

0.00%

ASX RANK

1,819

/2,047

SECTOR RANK

161

/168

SHARES OUTSTANDING

510.04m
ASX:ESE

eSense-Lab Ltd

Health

eSense-Lab Ltd (ESE) is a unique pharmatech company with multi- disciplinary R&D expertise, unique reverse engineering capabilities, and game-changing techniques that enable us to re- engineer the chemical composition found in plants, and re- formulate them for numerous commercial applications. The Company is a technology and research and development company specializing in the commercialization of the phytochemical profiling of plants. The Company combines genetics, mRNA, protein expression and phytochemical profiles to generate a comprehensive model of targeted plants.

Read more

Market Cap

$9.18m

Price at Close

$0.018

4w avg. Volume

0.00

4w avg. Turnover

$0.00

ASX:ESE is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.